Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1982 Apr 1;126(7):798–802.

Is a compromised interferon response an etiologic factor in Reye's syndrome?

K R Rozee, S H Lee, J F Crocker, S Digout, E Arcinue
PMCID: PMC1863073  PMID: 6176306

Abstract

Young mice injected with sublethal doses of Toximul MP8, a typical commercial polyoxyethylene ether-based emulsifier, died more frequently when infected with encephalomyocarditis virus than did control mice. Lymphocytes taken from emulsifier-injected mice responded poorly to interferon induction, unlike lymphocytes from control animals. Interferon protected control mice against viral encephalomyocarditis, but such protection was not equally demonstrable in emulsifier-injected mice. These data suggest that the enhanced lethality of encephalomyocarditis virus in emulsifier-injected mice is associated with and perhaps caused by a compromised interferon response in these animals. Since these emulsifiers are commonly found in the environment in areas where forests are sprayed with pesticides, a group of children suffering from Reye's syndrome who lived in such areas was investigated. Blood samples were obtained from five children with influenza B-associated Reye's syndrome during their acute illness and during convalescence. Lymphocytes obtained from these samples and from peripheral blood samples from healthy children (controls) were induced to synthesize interferon by exposure to Newcastle disease virus. The lymphocytes from the convalescent patients and from the controls responded well to induction. However, the lymphocytes obtained from patients and from the controls responded well to induction. However, the lymphocytes obtained from patients during the acute phase of Reye's syndrome responded very poorly and produced significantly less interferon.

Full text

PDF
798

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corey L., Rubin R. J., Thompson T. R., Noble G. R., Cassidy E., Hattwick M. A., Gregg M. B., Eddins D. Influenza B-associated Reye's syndrome: incidence in Michigan and potential for prevention. J Infect Dis. 1977 Mar;135(3):398–407. doi: 10.1093/infdis/135.3.398. [DOI] [PubMed] [Google Scholar]
  2. Crispens C. G., Jr Preparation of lymphocytes from small volumes of peripheral mouse blood. Experientia. 1979 Jun 15;35(6):833–834. doi: 10.1007/BF01968281. [DOI] [PubMed] [Google Scholar]
  3. Crocker J. F., Bagnell P. C. Reye's syndrome: a clinical review. Can Med Assoc J. 1981 Feb 15;124(4):375-82, 425. [PMC free article] [PubMed] [Google Scholar]
  4. Crocker J. F., Ozere R. L., Safe S. H., Digout S. C., Rozee K. R., Hutzinger O. Lethal interaction of ubiquitous insecticide carriers with virus. Science. 1976 Jun 25;192(4246):1351–1353. doi: 10.1126/science.179146. [DOI] [PubMed] [Google Scholar]
  5. Crocker J. F., Rozee K. R., Ozere R. L., Digout S. C., Hutzinger O. Insecticide and viral interaction as a cause of fatty visceral changes and encephalopathy in the mouse. Lancet. 1974 Jul 6;2(7871):22–24. doi: 10.1016/s0140-6736(74)91351-8. [DOI] [PubMed] [Google Scholar]
  6. De Maeyer-Guignard J. Mouse leukemia: depression of serum interferon production. Science. 1972 Sep 1;177(4051):797–799. doi: 10.1126/science.177.4051.797. [DOI] [PubMed] [Google Scholar]
  7. Gresser I., Tovey M. G., Bandu M. E., Maury C., Brouty-Boyé D. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med. 1976 Nov 2;144(5):1305–1315. doi: 10.1084/jem.144.5.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Haller O., Arnheiter H., Gresser I., Lindenmann J. Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med. 1979 Mar 1;149(3):601–612. doi: 10.1084/jem.149.3.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Khan A., Hill N. O. Interferon treatment in immunosuppressed patients. Ann Allergy. 1980 May;44(5):289–289. [PubMed] [Google Scholar]
  10. Lee S. H., Epstein L. B. Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophages. Cell Immunol. 1980 Mar 1;50(1):177–190. doi: 10.1016/0008-8749(80)90016-7. [DOI] [PubMed] [Google Scholar]
  11. Lee S. H., Laltoo M., Crocker J. F., Rozee K. R. Emulsifiers that enhance susceptibility to virus infection: increased virus penetration and reduced interferon response. Appl Environ Microbiol. 1980 Oct;40(4):787–793. doi: 10.1128/aem.40.4.787-793.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Linnemann C. C., Jr, Shea L., Kauffman C. A., Schiff G. M., Partin J. C., Schubert W. K. Association of Reye's syndrome with viral infection. Lancet. 1974 Jul 27;2(7874):179–182. doi: 10.1016/s0140-6736(74)91481-0. [DOI] [PubMed] [Google Scholar]
  13. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  14. Nelson D. B., Hurwitz E. S., Sullivan-Bolyai J. Z., Morens D. M., Schonberger L. B. Reye's syndrome in the United States in 1977-1978, a non-influenza B virus year. J Infect Dis. 1979 Sep;140(3):436–439. doi: 10.1093/infdis/140.3.436. [DOI] [PubMed] [Google Scholar]
  15. O'Shaughnessy M. V., Lee S. H., Rozee K. R. Interferon inhibition of DNA synthesis and cell division. Can J Microbiol. 1972 Feb;18(2):145–151. doi: 10.1139/m72-024. [DOI] [PubMed] [Google Scholar]
  16. REYE R. D., MORGAN G., BARAL J. ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. A DISEASE ENTITY IN CHILDHOOD. Lancet. 1963 Oct 12;2(7311):749–752. doi: 10.1016/s0140-6736(63)90554-3. [DOI] [PubMed] [Google Scholar]
  17. Rozee K. R., Lee S. H., Crocker J. F., Safe S. H. Enhanced virus replication in mammalian cells exposed to commercial emulsifiers. Appl Environ Microbiol. 1978 Feb;35(2):297–300. doi: 10.1128/aem.35.2.297-300.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Virelizier J. L., Gresser I. Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. V. Protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice. J Immunol. 1978 May;120(5):1616–1619. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES